Basimglurant is a potent, selective, and orally bioavailable negative allosteric modulator of the mGlu5 receptor, exhibiting a Kd of 1.1 nM. It has been utilized in preclinical research for investigating neurological disorders, including depression and anxiety, in both in vitro and in vivo models.
